Quality improvement scorecards driving innovation and best practice in a large community oncology practice.

Current demographic-specific cancer incidence rates were calculated using the Surveillance Epidemiology and End Results database. Population projections from the Census Bureau were used to project ...

Responding to Patient Requests for Hastened Death: Physician Aid in Dying and the Clinical Oncologist Conversations regarding goals of care with patients who have advanced cancer still occur too late, ...

Comparison of Breast Cancer Recurrence and Outcome Patterns Between Patients Treated From 1986 to 1992 and From 2004 to 2008 Flow cytometry of peripheral blood lymphocytes revealed dramatic efflux of ...

Genomically Smoldering Multiple Myeloma Is Not a Distinct Entity But a Collection of Monoclonal Gammopathy of Undetermined Significance or Multiple Myeloma L.C. was supported in part by the UTC ...

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...

Initial Safety Report of NSABP C-08: A Randomized Phase III Study of Modified FOLFOX6 With or Without Bevacizumab for the Adjuvant Treatment of Patients With Stage II or III Colon Cancer ...

View all available purchase options and get full access to this article. Supported by Award No. R01CA139118 (A.T.) and Award No. P50CA08393 (A.T.) from the National Cancer Institute. Also supported by ...

Phase III, Randomized Study of the Effects of Parenteral Iron, Oral Iron, or No Iron Supplementation on the Erythropoietic Response to Darbepoetin Alfa for Patients With Chemotherapy-Associated Anemia ...

West German Study Group Phase III PlanB Trial: First Prospective Outcome Data for the 21-Gene Recurrence Score Assay and Concordance of Prognostic Markers by Central and Local Pathology Assessment ...

View all available purchase options and get full access to this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The ...

The guideline aims to optimize health and quality of life for the post-treatment prostate cancer survivor by comprehensively addressing components of follow-up care, including health promotion, ...